Latest Posters
    
        Poster
    
                            Refining Liquid Biopsy: Generating More Information From Cell Free DNA
    Liquid biopsy for profiling of cell free DNA (cfDNA) in blood holds huge promise to transform how we experience and manage cancer by early detection and identification of residual disease and subtype.  However, a standard blood draw yields an average of only 10 ng of cfDNA, of which DNA derived from the tumor is a small minority. 
        
    
        Poster
    
                            Accelerating Antibody Drug Development With Subdomain-Specific Affinity Chromatography
    Affinity purification platforms such as Protein A or L are well-established in the manufacturing process of therapeutic monoclonal antibodies. However, with the development of engineered modalities such as bi-specific antibodies, fragments and Fc-fusion proteins, challenges in the downstream process of these molecules arise.
        
    
        Poster
    
                            Kinetic Analysis: Spotting the Weakest Binders
    Designing and performing assays that accurately measure small molecule binding kinetics is an important part of the drug discovery process. It allows researchers to predict the efficacy of potential novel therapeutics and make quick decisions about weak binders. 
        
    
        Poster
    
                            The Latest Analytical Techniques for PFAS Monitoring
    This poster compilation outlines the latest LC-MS/MS and QTOF MS methods for accurate environmental monitoring. 
        
    
        Poster
    
                            Discover a New Approach to Modeling Neurodegeneration
    This poster demonstrates how a novel, precise and highly controlled iPSC reprogramming technology overcomes these limitations and enables the generation of mature cell types and isogenic models of neurodegenerative disease.
        
    
        Poster
    
                            Optimized Human iPSC-Derived Sensory Neurons for Pain and Neuropathy Research
    Many promising drugs which show efficacy in animal models have failed in the clinic due to interspecies variance in nociception mechanisms. Hence, consistent, scalable human in vitro models are required to accelerate potential therapeutics to the clinic.
        
    
        Poster
    
                            Generating Pure, Consistent GABAergic Neurons From hiPSCs
    While animal models and primary cells remain valuable resources, neuronal drug development faces many challenges. Not least, the variability and inaccuracy of traditional model systems can result in the failure to translate data into successful clinical trials.
        
    
        Poster
    
                            Oligonucleotide Mapping Analysis of Erythropoietin mRNA
    Increased demand has led to an overwhelming volume of LC-MS/MS data and a requirement for analytical software that can simplify its interpretation. This poster highlights a new, comprehensive software solution capable of eliminating the otherwise overwhelming efforts of manual data interpretation. 
        
    
        Poster
    
                            Functional, Reprogrammed Microglia To Study Neurodegeneration
    Microglia play key roles in neurogenesis, synaptic remodeling, and are the first responders to infection in the brain. Hence, disease-relevant cell models are key to the success of neuroimmune and neurodegeneration research. 
        
    
        Poster
    
                            Whole Transcriptome Expression of FFPE Samples
    Formaldehyde fixed & paraffin-embedded (FFPE) tissue blocks are one of the most commonly used and archived sample types. However, some preservation approaches can result in the degradation of RNA and hinder transcriptome profiling . 
        
            Advertisement